Page 4 - Jazz Pharmaceuticals Stock Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jazz pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jazz Pharmaceuticals Stock Down Today - Breaking & Trending Today

Employees Retirement System of Texas Has $6.79 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Employees Retirement System of Texas lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 12.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 46,380 shares of the specialty pharmaceutical company’s stock after selling 6,530 shares during the quarter. Employees Retirement System […] ....

United States , Neenam Patil , Jazz Pharmaceuticals Company Profile , Securities Exchange Commission , Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Quarter For Jazz Pharmaceuticals , Sequoia Financial Advisors , Advisors Inc , Needham Company , First Republic Investment Management Inc , Royal Bank , Cantor Fitzgerald , Jazz Pharmaceuticals Stock Down , Employees Retirement System , Free Report , Retirement System , Avenue Securities , Financial Advisors , First Republic Investment Management , Republic Investment Management , Pharmaceuticals Stock Down , Get Free Report , Exchange Commission , Visit Holdingschannel , Jazz Pharmaceuticals Daily ,

Renaissance Technologies LLC Sells 8,494 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Renaissance Technologies LLC cut its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Rating) by 0.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,290,015 shares of the specialty pharmaceutical company’s stock after selling 8,494 shares during the quarter. Renaissance Technologies LLC […] ....

Patricia Carr , Quadrant Capital Group , Jazz Pharmaceuticals , Securities Exchange Commission , Goldman Sachs Group , Jazz Pharmaceuticals Plc , Jazz Pharmaceuticals Stock Down , Needham Company , Renaissance Technologies , Huntington National Bank , Royal Bank , Quarter For Jazz Pharmaceuticals , Advisors Inc , News Ratings For Jazz Pharmaceuticals Daily , Get Rating , Avenue Securities , Financial Advisors , National Bank , Capital Group , Exchange Commission , Pharmaceuticals Stock Down , Pharmaceuticals Plc , Visit Holdingschannel , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Sec Filings ,

Globeflex Capital L P Has $154,000 Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Globeflex Capital L P lowered its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Rating) by 15.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 965 shares of the specialty pharmaceutical company’s stock after selling 174 shares during the quarter. Globeflex Capital […] ....

Patricia Carr , Huntington National Bank , Needham Company , Securities Exchange Commission , Royal Bank , Advisors Inc , Quarter For Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Stock Down , Jazz Pharmaceuticals , Quadrant Capital Group , Jazz Pharmaceuticals Plc , Goldman Sachs Group , Get Rating , Avenue Securities , Financial Advisors , National Bank , Capital Group , Exchange Commission , Pharmaceuticals Stock Down , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans decreased its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Rating) by 43.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,614 shares of the specialty pharmaceutical company’s stock after selling 36,676 shares during the […] ....

Patricia Carr , Finbar Larkin , Jazz Pharmaceuticals , Needham Company , Jazz Pharmaceuticals Plc , Jazz Pharmaceuticals Stock Down , Thrivent Financial For Lutherans , Advisors Inc , Goldman Sachs Group , Quarter For Jazz Pharmaceuticals , Huntington National Bank , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Profile , Royal Bank , Quadrant Capital Group , Us Capital Wealth Advisors , Securities Exchange Commission , Thrivent Financial , Get Rating , Capital Group , National Bank , Wealth Advisors , Exchange Commission , Pharmaceuticals Stock Down , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) Upgraded by StockNews.com to Strong-Buy

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday. JAZZ has been the topic of several other research reports. The Goldman Sachs Group upped their target price on shares of Jazz Pharmaceuticals […] ....

Finbar Larkin , Patricia Carr , Advisors Inc , Goldman Sachs Group , News Ratings For Jazz Pharmaceuticals Daily , First Republic Investment Management Inc , Needham Company , Jazz Pharmaceuticals Plc , Analyst Recommendations For Jazz Pharmaceuticals , Jazz Pharmaceuticals , Jazz Pharmaceuticals Stock Down , Sequoia Financial Advisors , Institutional Investors Weigh In On Jazz Pharmaceuticals , Get Rating , Pharmaceuticals Stock Down , Avenue Securities , Financial Advisors , First Republic Investment Management , Republic Investment Management , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Stocknews Com ,